tirzepatide phase 2 obesity pipeline Lilly's shows higher doses of Zepbound are in clinical trials : r/Zepbound Next Generation Drug Pipeline – Apitegromab Preserves Lean Mass with

Traditional formulations often suffer from issues like: Poor encapsulation of sensitive or water-repelling (hydrophobic) actives Inconsistent particle size, leading to unpredictable bioavailability and targeting Rapid degradation or leakage, resulting in short shelf life Difficulties maintaining performance when scaling from lab to production Liposome encapsulation solves these problems by: Maximizes absorption, especially for oral and topical delivery Extends circulation time for longer therapeutic effect Minimizes toxicity through targeted or controlled release Shields fragile actives such as mRNA, enzymes, and probiotics from degradation At BOC Sciences, we address these obstacles head-on through advanced liposome encapsulation technology

Using the standard titration schedule, reaching 1.0 mg from a 0.25 mg restart takes approximately 8-12 weeks

Microdosing protocols Some patients and providers explore microdosing tirzepatide, using smaller, more frequent doses rather than the standard weekly injection

Please note that individual outcomes vary